Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon E Maynard

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Obstetrics and Gynecology|March 23, 2013
Gestational angiogenic biomarker patterns in high risk preeclampsia groupsSharon E Maynard, Sybil L Crawford, Susanne Bathgate, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 27, 2013
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk womenTiffany A Moore Simas, Sybil L Crawford, Susanne Bathgate, et al.
American Journal of Obstetrics and Gynecology|January 30, 2008
Circulating angiogenic factors in singleton vs multiple-gestation pregnanciesSharon E Maynard, Tiffany A Moore Simas, Matthew J Solitro, et al.
American Journal of Obstetrics and Gynecology|September 11, 2007
Angiogenic factors for the prediction of preeclampsia in high-risk womenTiffany A Moore Simas, Sybil L Crawford, Matthew J Solitro, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 7, 2012
Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsiaAndreea G Moore, Heather Young, Jennifer M Keller, et al.
International Journal of Molecular Sciences|June 5, 2015
Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of PreeclampsiaColby A Souders, Sharon E Maynard, Jing Yan, et al.
The New England Journal of Medicine|September 8, 2006
Soluble endoglin and other circulating antiangiogenic factors in preeclampsiaRichard J Levine, Chun Lam, Cong Qian, et al.
The Journal of Clinical Investigation|March 6, 2003
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaSharon E Maynard, Jiang-Yong Min, Jaime Merchan, et al.
The New England Journal of Medicine|February 7, 2004
Circulating angiogenic factors and the risk of preeclampsiaRichard J Levine, Sharon E Maynard, Cong Qian, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 2021
Assessing Nephrology Fellows' Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad NewsLisa K Prince, Anna M Howle, Jeffrey Mikita, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Obstetrics and Gynecology|March 23, 2013
Gestational angiogenic biomarker patterns in high risk preeclampsia groupsSharon E Maynard, Sybil L Crawford, Susanne Bathgate, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 27, 2013
Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk womenTiffany A Moore Simas, Sybil L Crawford, Susanne Bathgate, et al.
American Journal of Obstetrics and Gynecology|January 30, 2008
Circulating angiogenic factors in singleton vs multiple-gestation pregnanciesSharon E Maynard, Tiffany A Moore Simas, Matthew J Solitro, et al.
American Journal of Obstetrics and Gynecology|September 11, 2007
Angiogenic factors for the prediction of preeclampsia in high-risk womenTiffany A Moore Simas, Sybil L Crawford, Matthew J Solitro, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 7, 2012
Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsiaAndreea G Moore, Heather Young, Jennifer M Keller, et al.
International Journal of Molecular Sciences|June 5, 2015
Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of PreeclampsiaColby A Souders, Sharon E Maynard, Jing Yan, et al.
The New England Journal of Medicine|September 8, 2006
Soluble endoglin and other circulating antiangiogenic factors in preeclampsiaRichard J Levine, Chun Lam, Cong Qian, et al.
The Journal of Clinical Investigation|March 6, 2003
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaSharon E Maynard, Jiang-Yong Min, Jaime Merchan, et al.
The New England Journal of Medicine|February 7, 2004
Circulating angiogenic factors and the risk of preeclampsiaRichard J Levine, Sharon E Maynard, Cong Qian, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 20, 2021
Assessing Nephrology Fellows' Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad NewsLisa K Prince, Anna M Howle, Jeffrey Mikita, et al.
Pageof 2